HK$
0.03
May 14
Business Description
China NT Pharma Group Co Ltd
NAICS : 325412
ISIN : KYG2114L1059
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -1.03 | |||||
Debt-to-Equity | -1.02 | |||||
Debt-to-EBITDA | -75.81 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -13 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -69.4 | |||||
3-Year EPS without NRI Growth Rate | 53.3 | |||||
3-Year FCF Growth Rate | 175.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 67.45 | |||||
9-Day RSI | 61.97 | |||||
14-Day RSI | 56.29 | |||||
6-1 Month Momentum % | -71.79 | |||||
12-1 Month Momentum % | -60 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.02 | |||||
Quick Ratio | 0.02 | |||||
Days Inventory | 191.61 | |||||
Days Sales Outstanding | 1239.65 | |||||
Days Payable | 215.14 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -11.5 | |||||
Shareholder Yield % | 366.97 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -311.42 | |||||
Operating Margin % | -763.05 | |||||
Net Margin % | -1949.3 | |||||
FCF Margin % | 685.23 | |||||
ROA % | -17.86 | |||||
ROIC % | -3.62 | |||||
ROC (Joel Greenblatt) % | -1.36 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Price-to-Free-Cash-Flow | 2.31 | |||||
Price-to-Operating-Cash-Flow | 0.97 | |||||
EV-to-EBIT | -86.81 | |||||
EV-to-EBITDA | -86.81 | |||||
EV-to-Revenue | 53.63 | |||||
EV-to-FCF | 7.83 | |||||
Earnings Yield (Greenblatt) % | -1.15 | |||||
FCF Yield % | 32.27 |